Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Martín-Martín L
- López A
- Vidriales B
- Caballero MD
- Rodrigues AS
- Ferreira SI
- Lima M
- Almeida S
- Valverde B
- Martínez P
- Ferrer A
- Candeias J
- Ruíz-Cabello F
- Buadesa JM
- Villamor N
- Orfao A
- Almeida J
Grupos
Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare subtype of leukemia/lymphoma, whose diagnosis can be difficult to achieve due to its clinical and biological heterogeneity, as well as its overlapping features with other hematologic malignancies. In this study we investigated whether the association between the maturational stage of tumor cells and the clinico-biological and prognostic features of the disease, based on the analysis of 46 BPDCN cases classified into three maturation-associated subgroups on immunophenotypic grounds. Our results show that blasts from cases with an immature plasmacytoid dendritic cell (pDC) phenotype exhibit an uncommon CD56(-) phenotype, coexisting with CD34(+) non-pDC tumor cells, typically in the absence of extramedullary (e.g. skin) disease at presentation. Conversely, patients with a more mature blast cell phenotype more frequently displayed skin/extramedullary involvement and spread into secondary lymphoid tissues. Despite the dismal outcome, acute lymphoblastic leukemia-type therapy (with central nervous system prophylaxis) and/or allogeneic stem cell transplantation appeared to be the only effective therapies. Overall, our findings indicate that the maturational profile of pDC blasts in BPDCN is highly heterogeneous and translates into a wide clinical spectrum -from acute leukemia to mature lymphoma-like behavior-, which may also lead to variable diagnosis and treatment.
Datos de la publicación
- ISSN/ISSNe:
- 1949-2553, 1949-2553
- Tipo:
- Article
- Páginas:
- 19204-19216
- PubMed:
- 26056082
- Factor de Impacto:
- 2,260 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Oncotarget IMPACT JOURNALS LLC
Citas Recibidas en Web of Science: 72
Documentos
- No hay documentos
Filiaciones
Keywords
- blastic plasmacytoid dendritic cell neoplasm; flow cytometry; maturation profile; acute leukemia; lymphoma
Proyectos y Estudios Clínicos
RED DE INVESTIGACION COOPERATIVA DE CANCER
RD06/0020/0031 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
INTENSIFICACION DR. JAVIER DE LA RUBIA COMOS
Investigador Principal: JAVIER DE LA RUBIA COMOS
INT11/040 . 2012
RED TEMATICA DE INVESTIGACION COOPERATIVA EN CANCER (RTICC)
Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO
RD12/0036/0014 . INSTITUTO DE SALUD CARLOS III . 2013
ESTUDIO DE MUTACIONES PREEXISTENTES EN LAS CÉLULAS MADRE HEMATOPOYÉTICAS EN PACIENTES CON NEOPLASIAS MIELOIDES RELACIONADAS CON LA TERAPIA.
Investigador Principal: GUILLERMO SANZ SANTILLANA
PI14/01649 . INSTITUTO DE SALUD CARLOS III . 2015
Registro de Hemoglobinuria Paroxística Nocturna (HPN).
Investigador Principal: ISIDRO JARQUE RAMOS
ALE-ECU-2009-01 . 2010
BREATHER (PENTA 16): TERAPIA DE CICLO CORTO (5 DIAS SI /2 DIAS NO) PARA JOVENES INFECTADOS VIH-1.
Investigador Principal: DESAMPARADOS PEREZ TAMARIT
PENTA16 . 2011
ESTUDIO FASE 3, MULTICENTRICO, ALEATORIZADO, ABIERTO Y DE GRUPOS PARALELOS PARA VALORAR LA EFICACIA Y SEGURIDAD DE LENALIDOMIDA (REVLIMID) FRENTE A CLORAMBUCILO COMO TERAPIA DE PRIMERA LINEA EN PACIENTES ANCIANOS CON LEUCEMIA LINFOCITICA CRONICA DE CELULA S B NO TRATADOS PREVIAMENTE (ENSAYO ORIGIN).
Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO
CC-5013-CLL-008 . 2010
ESTUDIO EN FASE I/II DE BÚSQUEDA DE DOSIS DE CH14.18/CHO EN INFUSIÓN CONTINUA COMBINADO CON ALDESLEUKINA (IL-2) SUBCUTÁNEA EN PACIENTES CON NEUROBLASTOMA PRIMARIO REFRACTARIO O EN RECAÍDA.
Investigador Principal: VICTORIA CASTEL SÁNCHEZ
012010 . 2012
ESTUDIO DE DISTINTAS SUBPOBLACIONES DE LINFOCITOS B CLONALES Y NORMALES EN INDIVIDUOS CON LEUCEMIA LINFÁTICA CRÓNICA
Investigador Principal: ISIDRO JARQUE RAMOS
ORF-ANT-2011-01 . 2013